Please ensure Javascript is enabled for purposes of website accessibility

Melissa M. Mitchell

Melissa Mitchell is an Intellectual Property Attorney in the Biotechnology & Chemical Practice Group. Melissa earned a Bachelor of Science in Biological Sciences from Mississippi State University followed by a Master of Science in Biomedical Science from the University of Mississippi Medical Center. Melissa’s practice primarily relates to the preparation and prosecution of biotechnology, chemical, and plant patents.

Melissa attended Washington University School of Law and graduated in 2021. While in law school, Melissa was a staff member of the Washington University Jurisprudence Review and a board member of the WashU Intellectual Property Law Association. Melissa also gained valuable experience in the Washington University Entrepreneurship & Intellectual Property Clinic.

  • Biotechnology Patents
  • Chemical Patents
  • Design Patents
  • Trademarks
  • Academic Research and Technology Transfer
  • Agritech
  • Animal Health
  • Chemistry, Material Sciences, and Nanotechnology
  • Food and Beverage Technologies
  • Medical Devices
  • Pharma and Nutra
  • Plant Breeding and Plant-Related Technology

Iowa State Bar Association

Iowa Intellectual Property Law Association

Washington University in St. Louis School of Law, J.D., 2021

University of Mississippi Medical Center, M.S., Biomedical Science, 2017

Mississippi State University, B.S., Biological Sciences, 2013


Int’l Pub. No. WO 2023/183907 “Analysis of Genomic Word Frameworks on Genomic Methylation Data”

A Match Made in Antitrust Heaven? A Liberalistic Exploration of the Medical Match’s Antitrust Exemption, 13 Wash. U. Juris. Rev. 121 (2020).


Iowa State Bar, 2021

U.S. Patent & Trademark Office, 2020

Washington University Jurisprudence Review, Notes Editor

CALI Excellence for the Future Award – Legal Practice I

Sandra Day O’Connor, First Woman on The Supreme Court, Dies at 93

Sandra Day O’Connor, the first woman to sit on the United States Supreme Court, has died at the age of 93 due to complications related to advanced dementia and a respiratory illness. As the first woman to serve on the nation’s highest court, Justice O’Connor shattered glass ceilings and paved the way for a more […]

Read Post →

Supreme Court Remands Toy Story “Lotso” Case to 9th Circuit

Following the Supreme Court’s decision earlier this month in the Jack Daniel’s dog toy trademark dispute, the Supreme Court has remanded a case against Disney to the Ninth Circuit. Lots-o’-Huggin’ Bear (aka “Lotso”), the strawberry-scented, sadistic antagonist in Disney’s Toy Story 3, is also the alleged villain of Diece-Lisa Indus., Inc. v. Disney Store USA, […]

Read Post →

First-Time Patent Filer? The USPTO Wants to Make You Special

As part of ongoing efforts to create a more equitable and diverse patent system, last month the USPTO and its Council for Inclusive Innovation (CI2) announced the First-Time Filer Expedited Examination Pilot Program. The goal of the program is to increase accessibility to the patent system for inventors who are new to the patent process. […]

Read Post →

Worldwide Plant Variety Application Filings Reached Record Highs in 2021

Despite a global economic downturn and the COVID-19 pandemic, a report recently published by the World Intellectual Property Organization (WIPO) reveals there was sustained growth in worldwide IP filings in 2021. From 2020, patent filings grew by 3.6%, trademark filings grew by 5.5%, and plant variety applications grew by a staggering 12%. This double digit […]

Read Post →

USPTO Extends Cancer Immunotherapy Pilot Program

The United States Patent and Trademark Office recently issued a notice extending the Cancer Immunotherapy Pilot Program (AKA “Patents 4 Patients”) until September 30, 2022. The program was first implemented in 2016 as part of the $1 billion National Cancer Moonshot initiative and allows for fast-track review of cancer immunotherapy-related patent applications without the need […]

Read Post →

Stay in Touch

Receive the latest news and updates from us and our attorneys.

Sign Up